No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
180 |
4. Check minimum number of eventsNone |
180 |
5. Include endpointsNone |
180 |
6. Filter based on genotype QC (FinnGen only) |
168 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Tick-borne viral encephalitis
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 168 | 89 | 79 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 56.53 | 55.59 | 57.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 180
- Matched controls
- 1800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
93.0
81
*
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
76.7
68
*
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
35.6
33
*
TAB00
NOMESCO Finland
Lumbar puncture
10.5
34.9
44
54
XA800
NOMESCO Finland
Neuropsychological investigation
11.5
33.0
38
41
R50.9
ICD-10 Finland
Fever, unspecified
5.9
27.1
65
158
A87.9
ICD-10 Finland
Viral meningitis, unspecified
+∞
23.4
22
*
AA1AD
NOMESCO Finland
CT of head and brain
4.5
21.7
83
289
A69.2
ICD-10 Finland
Lyme disease
8.3
21.5
31
44
A84.1
ICD-10 Finland
Central European tick-borne encephalitis
+∞
18.0
17
*
R4120
NOMESCO Finland
Occupational therapy
6.2
16.8
32
61
A84
ICD-10 Finland
Tick-borne viral encephalitis
+∞
14.8
14
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
12.8
33
82
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
12.6
12
*
0632A
ICD-9 Finland
Tick-borne viral encephalitis, Central European encephalitis[PUUTIAISEN VÄLITTÄMÄ ENKEFALIITTI (KUMLINGE)]
+∞
9.5
9
*
B34.9
ICD-10 Finland
Viral infection, unspecified
10.9
9.2
17
17
R4150
NOMESCO Finland
Neuropsychological rehabilitation
26.3
7.7
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
7.6
96
583
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
+∞
7.3
7
*
G03.9
ICD-10 Finland
Meningitis, unspecified
31.4
7.2
9
*
S12
ICPC
Insect bite/sting
3.5
7.2
27
87
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
6.6
28
98
N29
ICPC
Neurological sympt/complt other
11.6
6.4
11
10
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.2
6.3
16
28
N71
ICPC
Meningitis/encephalitis
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
55
15
52.36
91.57
1.1
1.0
—
—
—
0
0
51
12
58.91
87.75
1.1
1.3
—
—
—
0
0
87
117
13.46
67.65
3.3
2.4
26.27
7.43
au/ml
—
15
7
83
106
13.67
66.91
1.8
1.2
60.74
27.79
au/ml
—
12
7
56
39
20.39
65.14
1.1
1.2
58.19
290.32
e6/l
0.77
31
31
56
39
20.39
65.14
1.1
1.1
99.70
3.37
e6/l
3.05
30
30
53
5
148.80
52.08
1.0
1.2
—
—
—
0
0
51
6
117.45
48.86
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
8
90.46
48.24
1.0
1.3
—
—
—
0
0
38
24
19.80
45.67
1.3
1.1
—
—
—
0
0
29
40
8.45
20.57
1.1
1.1
—
—
—
0
0
25
7
41.12
20.44
1.3
1.4
2.15
2.09
mmol/l
—
25
7
25
37
7.69
16.60
1.1
1.3
—
—
—
0
0
33
76
5.09
14.01
1.4
1.8
—
—
—
0
0
18
7
28.32
13.66
1.0
1.0
—
—
—
0
0
19
9
23.41
13.65
1.1
1.0
—
—
—
0
0
21
15
15.67
13.13
1.2
1.9
—
—
—
0
0
59
219
3.52
13.12
1.5
1.9
—
—
—
0
0
24
44
6.14
12.98
1.3
2.0
—
—
—
0
0
21
19
12.35
11.90
1.0
1.2
—
—
—
0
0
15
7
23.20
10.88
1.0
1.1
—
—
—
0
0
44
155
3.43
10.40
1.5
1.8
—
—
—
0
0
17
13
14.29
10.40
1.2
2.1
—
—
—
0
0
42
161
3.10
8.54
1.5
1.8
—
—
—
0
0
7
0
+∞
7.34
1.0
0.0
—
—
—
0
0
53
258
2.49
6.71
2.1
2.7
0.61
0.96
e6/l
0.66
20
138
99
638
2.23
6.46
3.4
5.7
1.20
1.22
mmol/l
1.65
86
586
6
0
+∞
6.28
1.0
0.0
—
—
—
0
0
49
241
2.42
6.01
2.4
2.9
2.91
1.97
e6/l
0.21
19
121
132
974
2.33
5.96
3.0
3.1
—
—
—
0
0
121
874
2.17
5.58
7.7
10.0
4.20
4.09
e9/l
0.15
100
760
14
25
5.98
5.50
1.0
1.4
254.50
216.17
u/ml
—
8
12
101
696
2.03
5.11
3.8
6.7
1.21
1.22
mmol/l
0.90
89
592
14
28
5.33
5.06
1.0
1.4
—
—
—
0
0
16
46
3.72
5.02
1.2
2.3
—
—
—
0
0
70
425
2.06
5.01
2.5
3.0
0.23
0.42
e6/l
0.74
45
309
82
534
1.98
4.78
2.0
1.9
96.69
94.68
pmol/l
0.11
42
269
138
1100
2.09
4.25
3.9
4.0
12.39
11.14
mm/h
0.49
132
1025
142
1153
2.10
4.03
7.4
7.8
74.77
79.33
u/l
0.63
137
1086
105
776
1.85
3.91
5.2
6.9
10.33
11.22
umol/l
0.62
98
740
12
28
4.51
3.89
1.0
1.4
—
—
—
0
0
170
1500
3.40
3.85
16.0
13.3
20.50
22.62
mg/l
0.48
154
1164
6
5
12.34
3.79
1.2
1.0
1255.00
1999.20
miu/ml
—
6
5
109
825
1.81
3.66
3.5
4.5
6.64
6.62
mmol/l
0.01
103
767
10
22
4.75
3.48
1.0
1.9
—
—
—
0
0
10
22
4.75
3.48
1.0
1.9
—
—
—
0
0
76
529
1.76
3.30
2.7
3.2
—
—
—
0
0
79
565
1.71
3.06
2.3
2.4
73.23
75.11
nmol/l
0.24
70
511
83
608
1.68
2.90
3.2
4.6
35.67
35.94
g/l
0.20
78
578
7
13
5.55
2.90
1.0
2.1
—
—
—
0
0
7
13
5.55
2.90
1.0
2.1
—
—
—
0
0
7
13
5.55
2.90
1.0
2.1
—
—
—
0
0
11
33
3.48
2.86
1.1
1.8
—
—
—
0
0
43
265
1.82
2.75
3.5
3.6
37.24
77.20
ng/l
0.67
33
205
14
56
2.63
2.60
1.2
1.8
—
—
—
0
0
6
12
5.13
2.42
1.0
1.0
—
—
—
0
0
5
8
6.39
2.38
1.2
1.0
—
—
—
0
0
5
8
6.39
2.38
1.0
2.4
—
—
—
0
0
5
8
6.39
2.38
1.0
2.4
—
—
—
0
0
5
8
6.39
2.38
1.0
1.0
—
—
—
0
0
172
1601
2.67
2.34
17.0
15.7
72.78
77.89
umol/l
3.28
172
1601
9
28
3.33
2.34
1.2
1.6
—
—
—
0
0
10
34
3.05
2.32
1.1
1.8
—
—
—
0
0
20
100
2.13
2.31
1.3
1.6
—
—
—
0
0
5
9
5.68
2.23
2.0
1.8
367.60
1060.00
u/ml
—
5
9
49
337
1.62
2.09
1.5
1.5
21.33
21.87
nmol/l
0.10
37
289
82
636
1.53
2.08
9.5
11.3
1.02
1.22
inr
6.00
12
191
77
594
1.52
1.98
2.4
2.7
149.38
118.95
ug/l
0.54
68
555
25
146
1.83
1.90
3.6
6.9
1.94
1.15
mmol/l
0.54
19
118
6
17
3.61
1.85
1.2
1.1
—
—
—
0
0
16
81
2.07
1.81
1.1
1.4
—
—
—
0
0
39
550
0.63
1.79
2.7
3.5
—
—
—
0
0
52
377
1.53
1.75
2.0
2.7
9243.31
4471.63
umol/l
0.22
45
334
5
13
3.92
1.72
1.0
1.3
—
—
—
0
0
45
317
1.56
1.72
1.4
1.6
0.98
1.18
mg/l
0.30
32
253
29
183
1.70
1.71
5.1
4.4
34.07
32.15
%
0.38
15
123
7
25
2.87
1.66
1.0
1.1
—
—
—
0
0
5
14
3.64
1.62
1.0
1.6
—
—
—
0
0
5
14
3.64
1.62
1.0
1.6
—
—
—
0
0
23
139
1.75
1.57
1.7
2.4
11.69
13.68
nmol/l
0.66
23
130
7
27
2.66
1.53
1.1
1.7
—
—
—
0
0
20
117
1.80
1.52
2.0
2.7
0.23
0.22
g/l
0.43
20
108
7
151
0.44
1.52
2.7
3.4
—
—
—
0
0
9
37
2.51
1.50
1.0
1.4
—
55.84
—
0
5
11
52
2.19
1.47
1.1
1.2
—
—
—
0
0
41
296
1.50
1.40
3.1
2.9
0.45
0.73
ug/l
3.34
23
188
148
1356
1.51
1.31
4.6
4.5
1.73
1.90
mu/l
1.23
134
1234
5
18
2.83
1.29
1.2
1.6
—
—
—
0
0
5
18
2.83
1.29
1.4
1.1
—
—
—
0
0
9
44
2.10
1.29
1.1
2.0
0.00
0.00
g/l
—
9
44
9
44
2.10
1.29
1.1
2.0
0.00
0.00
g/l
—
9
44
8
35
2.34
1.28
1.3
1.5
—
—
—
0
0
8
35
2.34
1.28
1.3
1.5
—
—
—
0
0
68
548
1.39
1.28
2.9
3.7
64.65
33.68
ng/l
0.32
51
381
5
19
2.68
1.22
1.0
1.3
—
—
—
0
0
5
19
2.68
1.22
1.0
1.3
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
51
398
1.39
1.15
3.6
4.3
22.97
21.31
%
0.22
17
180
7
32
2.23
1.09
1.0
1.5
—
—
—
0
0
14
82
1.77
1.08
3.9
9.2
94.17
93.44
%
0.15
14
82
61
496
1.35
1.06
5.1
4.6
2.98
1.88
ug/l
0.46
52
445
9
46
2.01
1.05
1.1
2.0
0.00
0.00
g/l
—
9
46
57
460
1.35
1.04
2.1
2.4
51.92
68.57
u/l
0.89
52
430
5
22
2.31
1.04
1.2
1.6
—
—
—
0
0
174
1683
2.02
0.98
22.9
19.6
134.61
137.14
g/l
1.86
174
1662
59
483
1.33
0.98
3.6
3.5
2.32
2.35
mmol/l
0.56
46
433
174
1680
2.07
0.97
22.8
19.5
39.65
40.76
%
1.49
168
1590
7
37
1.93
0.95
1.0
1.2
—
—
—
0
0
151
1414
1.42
0.94
15.6
13.0
84.83
82.94
ml/min/173m2
0.58
129
1169
40
310
1.37
0.94
2.1
2.1
3.70
2.99
mg/l
0.50
29
274
13
79
1.70
0.90
3.2
5.4
25.05
24.68
mmol/l
0.15
13
79
6
29
2.10
0.90
1.5
1.3
—
—
—
0
0
12
73
1.69
0.84
1.0
1.0
—
—
—
0
0
48
390
1.31
0.83
2.4
3.0
714.13
995.04
ng/l
0.52
42
315
6
32
1.90
0.82
1.2
1.5
—
—
—
0
0
11
66
1.71
0.80
1.5
2.4
35.82
40.19
u/l
0.33
11
61
121
1110
1.27
0.78
3.5
3.9
14.93
14.77
pmol/l
0.24
105
1008
23
169
1.41
0.74
6.1
7.8
—
—
—
0
0
10
61
1.68
0.70
1.2
2.5
—
—
—
0
0
40
329
1.28
0.63
2.3
2.1
—
—
—
0
0
8
53
1.53
0.59
1.0
1.2
—
—
—
0
0
8
53
1.53
0.59
1.0
1.2
—
—
—
0
0
8
53
1.53
0.59
1.1
2.5
—
—
—
0
0
21
159
1.36
0.58
2.0
1.8
300.43
371.90
nmol/l
1.26
21
146
34
277
1.28
0.58
1.4
1.6
—
—
—
0
0
10
148
0.66
0.58
1.9
2.0
—
—
—
0
0
28
223
1.30
0.57
1.5
1.4
—
—
—
0
0
41
345
1.24
0.54
1.2
1.3
0.55
1.19
u/ml
—
8
106
23
180
1.32
0.53
4.2
6.9
104.04
104.56
mmol/l
0.24
23
180
12
167
0.70
0.52
2.0
2.1
—
—
—
0
0
151
1450
1.26
0.49
4.4
4.3
5.97
5.88
mmol/l
0.19
135
1340
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
151
1458
1.22
0.40
4.5
3.9
1.23
1.32
mmol/l
1.01
134
1357
5
35
1.44
0.39
1.2
1.4
—
—
—
0
0
5
36
1.40
0.38
1.4
1.4
—
—
—
0
0
6
41
1.48
0.36
1.2
1.8
—
—
—
0
0
6
41
1.48
0.36
1.5
1.2
—
—
—
0
0
6
43
1.41
0.35
1.0
1.3
—
2.31
—
0
7
6
45
1.34
0.34
1.7
2.6
—
—
—
0
0
77
715
1.13
0.33
2.5
3.4
0.00
0.00
estimate
—
5
134
39
437
0.86
0.31
2.8
3.8
5.70
8.42
mg/mmol
0.42
24
269
29
251
1.19
0.31
2.3
3.1
2.45
2.45
mmol/l
0.00
24
221
7
54
1.31
0.31
1.0
1.5
—
—
—
0
0
9
72
1.26
0.26
1.4
2.9
0.78
1.12
%
—
9
72
28
247
1.16
0.24
1.1
1.2
1.44
8.16
u/ml
—
8
101
5
40
1.26
0.22
1.6
1.4
—
—
—
0
0
5
41
1.23
0.22
1.6
1.5
—
—
—
0
0
30
269
1.14
0.21
1.3
1.3
60.57
32.95
iu/ml
—
7
101
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.7
—
13.59
—
0
13
7
58
1.22
0.18
1.1
1.8
—
—
—
0
0
27
244
1.13
0.17
1.4
1.7
747.83
1196.77
nmol/l
2.62
18
185
74
706
1.08
0.17
4.0
4.6
0.00
0.00
estimate
—
5
146
9
81
1.12
0.15
1.0
1.3
—
—
—
0
0
67
642
1.07
0.13
2.5
2.4
—
—
—
0
0
15
162
0.92
0.06
1.7
1.7
—
—
—
0
0
140
1385
1.05
0.06
5.3
5.4
39.57
39.63
mmol/mol
0.02
130
1306
152
1533
0.95
0.06
5.3
4.8
2.83
2.82
mmol/l
0.07
134
1434
152
1507
1.06
0.05
5.2
4.4
4.76
4.72
mmol/l
0.21
137
1419
132
1313
1.02
0.01
20.4
16.5
14.50
14.89
%
0.39
132
1301
42
424
0.99
0.00
1.6
1.7
1.37
1.41
mmol/l
0.10
35
360
150
1501
1.00
0.00
5.0
4.4
1.52
1.45
mmol/l
1.04
135
1403
0
5
0.00
0.00
0.0
11.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
113.40
—
0
5
6
61
0.98
0.00
3.5
3.9
54.18
52.06
%
—
6
61
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
7.74
—
0
8
0
7
0.00
-0.00
0.0
2.3
—
60.71
—
0
7
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
70.21
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_TICK_BORNE_ENCEPHALITIS_WIDE – Tick-borne viral encephalitis
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).